Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs

E-ISSN： 2212-3903|10|2|66-81

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.10, Iss.2, 2015-08, pp. : 66-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Classical Neurotransmitters and Neuropeptides Involved in Schizophrenia: How to Choose the Appropriate Antipsychotic Drug?

Current Drug Therapy, Vol. 8, Iss. 2, 2013-06 ,pp. : 132-143

Bentham Science Publishers

Access to resources Recommend Favorite

Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis

By Garrood T. Scott D.L.

BioDrugs, Vol. 15, Iss. 8, 2001-08 ,pp. : 543-561

Adis International

Access to resources Recommend Favorite

Smarter Drugs: A Focus on Pan-Specific Monoclonal Antibodies

By Fagète Séverine Fischer Nicolas

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 357-364

Adis International

Access to resources Recommend Favorite

The Therapeutic Potential of Intrabodies in Neurologic Disorders: Focus on Huntington and Parkinson Diseases

By Messer Anne McLear Julie

BioDrugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 327-333

Adis International

Access to resources Recommend Favorite

Effects of Instructional Focus on Learning a Classical Ballet Movement, the Pirouette

By Denardi Renata Alvares

Journal of Dance Medicine & Science, Vol. 17, Iss. 1, 2013-03 ,pp. : 18-23

J. Michael Ryan Publishing Inc.

Access to resources Recommend Favorite